Qianhai Health Holdings (HKSE:00911) Common Stock: HK$67.8 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00911 Qianhai Health Holdings Ltd HKSE:00911
39 GF Score
Price HK$0.47
GF Value HK$0.22
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Qianhai Health Holdings Common Stock?

Qianhai Health Holdings HKSE:00911 -4.08% 39 Common Stock is HK$67.8 Mil as of Dec. 2025. GuruFocus rates HKSE:00911 with a GF Score™ of 39/100 and a GF Value™ of HK$0.22 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Qianhai Health Holdings's quarterly common stock stayed the same from Dec. 2024 (HK$67.8 Mil) to Jun. 2025 (HK$67.8 Mil) and stayed the same from Jun. 2025 (HK$67.8 Mil) to Dec. 2025 (HK$67.8 Mil).

Qianhai Health Holdings's annual common stock stayed the same from Dec. 2023 (HK$67.8 Mil) to Dec. 2024 (HK$67.8 Mil) and stayed the same from Dec. 2024 (HK$67.8 Mil) to Dec. 2025 (HK$67.8 Mil).

Qianhai Health Holdings Common Stock Historical Data

* Premium members only.

The historical data trend for Qianhai Health Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qianhai Health Holdings Common Stock Chart

Qianhai Health Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.78 67.78 67.78 67.78 67.78

Qianhai Health Holdings Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.78 67.78 67.78 67.78 67.78
HKSE:00911
39GF Score
Qianhai Health Holdings Ltd HKSE:00911
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qianhai Health Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of HK$67.8 Mil mean?
Qianhai Health Holdings (HKSE:00911) has a Common Stock of HK$67.8 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Qianhai Health Holdings and its competitors.
Is Qianhai Health Holdings' Common Stock too high?
Qianhai Health Holdings' current Common Stock is HK$67.8 Mil. Overall, Qianhai Health Holdings has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qianhai Health Holdings' Common Stock compare to ZTS?
Qianhai Health Holdings' Common Stock of HK$67.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Qianhai Health Holdings and its competitors. Qianhai Health Holdings's current Common Stock is HK$67.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qianhai Health Holdings stock overvalued right now?
Based on GuruFocus' analysis, Qianhai Health Holdings (HKSE:00911) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.22, compared to a current price of HK$0.47 — trading 113.6% above its estimated fair value. The current Common Stock is HK$67.8 Mil. Qianhai Health Holdings' overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Qianhai Health Holdings (HKSE:00911), the current Common Stock is HK$67.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qianhai Health Holdings (HKSE:00911) Overvalued in 2026?

Based on GuruFocus' analysis, Qianhai Health Holdings stock appears to be overvalued. The current stock price of HK$0.47 is trading 113.6% above its estimated GF Value™ of HK$0.22. GuruFocus considers Qianhai Health Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:00911:

  • Common Stock: HK$67.8 Mil
  • GF Value™: HK$0.22 vs. price of HK$0.47 (113.6% above fair value)
  • GF Score™: 39/100 with 2 warning signs

No single metric tells the full story. See the HKSE:00911 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qianhai Health Holdings Business Description

Address 177-183 Wing Lok Street, Room 301-3, 3rd Floor, Wing Tuck Commercial Centre, Sheung Wan, Hong Kong, HKG
Qianhai Health Holdings Ltd principally engaged in the sale of health products and electronic component products. It includes Chinese herbal medicines, skin-care and other healthcare products, and the sale of information technology components. The operating segments of the group are Healthcare products and Electronic component products. Healthcare products include the sale of healthcare products, including Chinese herbal medicines, skincare, and other healthcare products. Electronic component products include the sale of information technology components products including central processing units and semiconductors. The group's revenue is all derived from Hong Kong.
39GF Score

Get the complete analysis for HKSE:00911

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.47
Price
HK$0.22
GF Value